We are committed to improving patient lives worldwide. As a global pharmaceutical company, we expand access to high-quality medicines through strategic partnerships and regulatory excellence.
Our portfolio includes niche and complex generics, first-to-file and first-to-launch products, and value-added opportunities tailored for global partners.
Built on trust and driven by innovation, Anveira is shaping a healthier tomorrow.
Established in
0
Experience
2-3 decades of leadership experience in pharma.
Why US
We believe that every business is unique, and we pride ourselves on delivering the most advanced solutions.
Nimble and Flexible
A model with an access of diversified technologies and scalability to pursue value added portfolio expansion
Nimble execution
Flexible business model
Adaptive growth strategy
Rapid Commercialization
Advanced Innovation
Regulatory Agility
Acceleration to market
A quick turnaround for bringing value added Gx products with robust R&D, advanced technologies leverage, optimized regulatory strategies
Strong LoE Pipeline
Opportunity Prioritization
Strategic Execution
Robust Pipeline
Leveraging a robust pipeline of upcoming Loss of Exclusivity (LoE) assets, coupled with industry-leading capabilities in evaluating, prioritizing, and executing high-potential opportunities
IP creation
Increased value proportion for licensed partners through markets extension and IP ownership
Global Reach
Proprietary IP
Partner Empowerment
